Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP vs Steroid in Carpal Tunnel Syndrome
NCT04000932Phase 3Unknown
- Sponsor
- Baskent University
- Start
- Jul 2018
- Primary completion
- Dec 2019
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of autologous platelet-rich plasma in carpal tunnel syndrome (CTS), sponsored by Baskent University. Primary endpoint: Median nerve sensory conduction velocity at 3 months. Status: unknown.
02
Drugs
autologous platelet-rich plasma
03
Conditions
carpal tunnel syndrome (CTS)
Beyond the preview
Go deeper on NCT04000932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04000932.